-The Hindu Every biomedical and health research involving human participants, whether in conventional areas, or in new evolving specialised fields, will have to be conducted in accordance with the provisions of the proposed Biomedical and Health Research Regulation Bill, 2013. Research on human subjects in the specified areas like assisted reproductive technology (ART); organ, tissue and cell therapy; genetic and genomic studies including techniques of genetic engineering and gene therapy; nano medicines;...

-The Hindu Chronic corruption and lack of affordable access to treatments for serious diseases in the public health system stand exposed in the kidney commerce scandal in Tamil Nadu's Dharmapuri district. Nothing can be a greater irony than the existence of such thriving sale of organs in a State that also has perhaps the best-run programme for donation of kidneys, livers, hearts and lungs by deceased donors. It is no small...

-The Times of India NEW DELHI: India will soon have separate guidelines for eye donations and transplantation. The Union health ministry, in its bid to augment eye donations in the country, has set up a committee, headed by the chief of R P Eye Centre at AIIMS, Dr R V Azad, to frame new rules which will separate eye retrieval and transplant from organ donations. "Unlike a heart, kidney and other organs,...

-The Times of India MUMBAI: Instead of simplifying the process for organ donation, the Centre seems to be imposing more bureaucratic hurdles and adding to the trauma of donors' family members. A draft of fresh national guidelines for organ transplant says forensic departments of government hospitals will play a pivotal role in organ donation. The problem, say experts, is that grieving relatives may have to wait longer-first, for busy, overworked forensic experts...

-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...